1Saunders ML,Dische S,Barrett A,et al.Randomized multicentre trials of CHART vs conventional radiotherapy in head and neck and non small cell lung cancer.an interim report.CHART steering committee.Br J Cancer 1996,73:1455-1461.
2Herskovic A,Farnan N,Nemas W.et al.Tolerance and toxicity of T L D accelerated hyperfractionated radiotherapy for bronchogenic cancer RTOG 92-05 Int J Radiat Oncol Biol Phys,1995,32(suppl):278-285.
3Kikuch Y.Study on clinical application of multiple fractions per day radiation therapy with concomitant boost technique for esophageal cancer.Hokkaido Igaku Zasshi 1993,68:537-541.
4Wang CC edt.Radiation therapy for head and neck neoplasnis.A JW and Sons.Inc Pub,1997 New York.63-79.
5Ang KK,Peters LJ,Weber RS et al.Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx.Int J Radiat Oncol Biol Phys,1990,19:1339-1347.
6Mak AC,Horrison WH.Garden AS,et al.Base of tongue carcinoma.treatment results using concomitant bosst radiotherapy.Int J Radiat Oncol Biol Phys,1995,33:289-297.
9Begg AC,Hofland I,Blabekke M V,et al.Predictive value of potential doubling time for radiotherapy of head and neck tumor patients results from the EORTC cooperative trial 22851.Seminars in Radiar Oncol 1992,2:22-25.
10Awwad HK.Uncoventional fractionation studies and Tpot correction.Seminars in Radiat Oncol,1992,2:62-66.
